Three molecular determinants of malignant conversion and their potential as therapeutic targets

Curr Opin Oncol. 1999 Jan;11(1):58-67. doi: 10.1097/00001622-199901000-00013.

Abstract

The past decade has been marked by an explosion of knowledge regarding the dysregulation of cancer at the molecular level. It has become apparent that oncogenes, tumor suppressor genes, and other ancillary molecules interact in complex pathways that govern cellular homeostasis. We review three molecular events that have been implicated in tumorigenesis and define pathways ripe for the development of new therapeutic approaches: 1) activation of telomerase, 2) dysregulation of the patched/sonic hedgehog pathway, and 3) mutation of the INK4 alpha-ARF locus.

Publication types

  • Review

MeSH terms

  • Cellular Senescence / physiology
  • Cyclin-Dependent Kinase Inhibitor p16
  • Enzyme Activation
  • Gene Expression Regulation, Neoplastic*
  • Hedgehog Proteins
  • Humans
  • Models, Genetic
  • Mutation
  • Neoplasms / etiology*
  • Neoplasms / genetics
  • Proteins / metabolism*
  • Telomerase / metabolism*
  • Trans-Activators*

Substances

  • Cyclin-Dependent Kinase Inhibitor p16
  • Hedgehog Proteins
  • Proteins
  • SHH protein, human
  • Trans-Activators
  • Telomerase